DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

Tech giants sign on to interoperability pledge Amazon, Google, IBM, Microsoft, Oracle, and Salesforce agree to common interest

Scottish radiologist shortage looming 'We are on red alert – there is absolutely no doubt about this'

GE Healthcare joins AdvaMed Access to global thought leadership and policy area expertise

In Korea and Italy, imaging OEMs face accusations of anti-competitive actions Are unfair tactics being used to hurt non-OEM equipment servicers?

Forces driving healthcare M&A activity Understanding why consolidation is going to continue

Boston Scientific to buy VENITI for $160 million Price may rise pending FDA approval of Vici Venous Stent

Sotera Health's Nordion closes sale of medical isotopes business to BWX Technologies About 150 employees will be transferred in the deal

FDA clears Aidoc AI solution for triaging head CT scans Flags acute intracranial hemorrhage cases by focusing on abnormal regions

Henry Ford Health System and GM enter "Direct to Employer" healthcare contract A first-of-its-kind arrangement for both organizations

Varian to acquire humediQ Global Bringing IDENTIFY automated workflow solution to surface-guided radiation therapy

RefleXion Medical's biology-guided
radiotherapy system

RefleXion raises $100 million for world’s first biology-guided radiotherapy system

John R. Fischer , Staff Reporter
RefleXion Medical has raised more than $100 million in a Series C round of funding for the development of the first and only biology-guided radiotherapy system (BgRT) for targeted cancer treatment.

The system is designed to irradiate multiple tumors in one session, a feature that RefleXion estimates will benefit many of the 600,000 U.S. patients diagnosed with metastatic cancer each year as well as increase access to care in underserved areas that lack trained technicians and qualified staff.

Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs



"Conventional radiotherapy systems are primarily focused on treating individual, solid-tumor cancers,” RefleXion Medical CTO and co-founder Sam Mazin told HCB News. “RefleXion's technology will be able to treat that disease while also expanding the addressable patient population by treating metastatic disease, which involves multiple tumors throughout the body.”

The World Health Organization predicts that more than 13 million global cancer deaths will occur in 2030, a number which the BgRT system is predicted to help reduce, partially by simplifying and automating the radiotherapy treatment process.

The procedure will start out with a PET imaging agent administered into a patient to identify tumors, sending off signals to RefleXion’s technology so that it may direct therapeutic X-rays to one or more of these malignancies in real time.

This will enable the BgRT system to deliver higher doses of radiation than conventional systems and spare a higher amount of surrounding healthy tissue.

In addition, it will also be able to automatically compensate for tumor motion while precisely targeting the disease, a feature that according to Todd Powell, president and CEO of RefleXion, could lead to the annual diagnosis of 750,000 U.S. patients with early stage diseases.

"The funds raised will set the stage for commercialization of our unique system. That includes manufacturing, facilities and staffing in areas of marketing, sales and service" he told HCB News.

Funding for this round was led by the Rise Fund, the global impact investment fund managed by TPG Growth, marking its first investment in health care technology.

Contributions were also made by T. Rowe Price Associates Inc.; China-focused health care investment firm GT Healthcare Capital Partners; Sofinnova Partners; KCK Group; Venrock; Pfizer Venture Investments; and Johnson & Johnson Innovation – JJDC Inc.

RefleXion Medical expects to be treating U.S. patients by mid-2019.

Back to HCB News
  Pages: 1

Business Affairs Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有